Australia - English - Department of Health (Therapeutic Goods Administration)

frontal medical pty ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharmaceutical industries europe b.v. - sumatriptan succinate - solution for injection - 12mg/1ml

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - botulinum toxin type a - injection, powder, for solution - 200 units - botulinum toxin type a 200 units

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - clostridium botulinum toxin type a - injection, powder, for solution - 50 units - clostridium botulinum toxin type a 50 units

United States - English - NLM (National Library of Medicine)

biomarin pharmaceutical inc. - pegvaliase (unii: n6uah27euv) (pegvaliase - unii:n6uah27euv) - palynziq is indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria (pku) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/l on existing management. none. risk summary based on findings in studies of pregnant animals without pku treated with pegvaliase-pqpz, palynziq may cause fetal harm when administered to a pregnant woman. limited available data with pegvaliase-pqpz use in pregnant women are insufficient to inform a drug-associated risk of adverse developmental outcomes. there are risks to the fetus associated with poorly controlled phenylalanine concentrations in women with pku during pregnancy including increased risk for miscarriage, major birth defects (including microcephaly, major cardiac malformations), intrauterine fetal growth retardation, and future intellectual disability with low iq; therefore, phenylalanine concentrations should be closely monitored in women with pku during pregnancy (see clinical considerations and data).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - salbutamol sulfate - solution for injection - 500microgram/1ml

United States - English - NLM (National Library of Medicine)

ventura corporation ltd - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - uses helps prevent sunburn. stop use and ask a doctor if rash occurs.

United States - English - NLM (National Library of Medicine)

ventura international ltd - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - uses helps prevent sunburn. stop use and ask a doctor if rash occurs.

United States - English - NLM (National Library of Medicine)

bel star s.a. (colombia) - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - uses helps prevent sunburn. stop use and ask a doctor if rash occurs.

United States - English - NLM (National Library of Medicine)

ventura corporation ltd - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - uses helps prevent sunburn. stop use and ask a doctor if rash occurs.